X4 Pharmaceuticals
XFOR
$1.01
Share price
3.49%
Change (1 day)
-54.50%
Change (1 year)
Categories
X4 Pharmaceuticals (XFOR) - Cash on Hand
Cash on Hand as of March 2024 : $80.86 M
According to X4 Pharmaceuticals
's latest financial reports the company has $80.86 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
X4 Pharmaceuticals - Cash on Hand chart (from 2016 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $0.12 B | 48.82% |
| 2021-12-31 | $81.78 M | 3.91% |
| 2020-12-31 | $78.7 M | -37.62% |
| 2019-12-31 | $0.12 B | 310.3% |
| 2018-12-31 | $30.75 M | -59.95% |
| 2017-12-31 | $76.79 M | 2430.25% |
| 2016-12-31 | $3.03 M | -55.1% |
| 2015-12-31 | $6.75 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.31 B | 291.72% | 🇺🇸 USA |